CALR and breast cancer: The surface exposure of CRT and HSP70 or HSP90 was also treated by CM-EE in mouse breast cancer cells (4T1-neu-HA cells), as in the treatment of human breast cancer cells, which increased as the drug-dependent concentration gradually increased (Figure 3(c)).